4543 — Terumo Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapHigh Flyer

Annual income statement for Terumo, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Tanshin
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	613,842	703,303	820,209	921,863	1,036,171
Cost of Revenue
Gross Profit	326,623	369,341	417,370	479,175	560,670
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	515,456	587,343	702,877	781,767	878,503
Operating Profit	98,386	115,960	117,332	140,096	157,668
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	97,060	114,501	116,137	140,829	154,574
Provision for Income Taxes
Net Income After Taxes	77,201	88,814	89,326	106,374	116,979
Minority Interest
Net Income Before Extraordinary Items
Net Income	77,268	88,814	89,326	106,374	116,979
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	77,272	88,813	89,325	106,374	116,978
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	50.6	59	60.7	73	79
Dividends per Share